Skip to NavigationSkip to content

Frank Pitzer made chief executive at NimbleGen

Published on: 07/04/10

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen.

Dr Pitzer has been with Roche for eight years, and the company said he would have instrumental role in guiding NimbleGen, a global leader in microarray tools for genetic discovery and analysis, through its next stage of growth.

He was most recently head of divisional quality and regulatory affairs at Roche Diagnostics and an active member of the Diagnostics Executive Committee.

“We are extremely excited to announce Dr Frank Pitzer as the chief executive of Roche NimbleGen and look forward to expanding the company’s position as a leading genomics solution provider,” said Manfred Baier, head of Roche Applied Science.

“Frank’s leadership skills and extensive experience in the life science industry make him the perfect fit to guide Roche NimbleGen through the next stages of growth. His valuable insight and outstanding management experience will further entrench the company as a leading manufacturer of microarray technologies.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches